Common side effects include nausea, diarrhea, constipation, vomiting and indigestion
Biocons Generics Business: Riding the GLP-1 Wave Biocons generics segment, which contributed 18% of the companys revenue , delivered an impressive 24% year-on-year growth , reaching 774 crore in Q2 FY26
Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995), including about retatrutide and Foundayo (orforglipron) as potential treatments for adults with obesity or type 2 diabetes and the timeline for future readouts, presentations, and other milestones relating to retatrutide and Foundayo and its clinical trials, and reflects Lilly's current beliefs and expectations
Contrave reviews In studies, over 56 weeks, the average weight loss in people taking Contrave was about 17 pounds